
Axpero 5 Tablet
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Axitinib (5mg)
Overview Axpero 5 Tablet
Axpero 5mg tablets are a medication used in kidney cancer treatment. This anti-neoplastic drug may be administered with or without food, but consistent daily timing optimizes effectiveness. Dosage and frequency are determined by your physician based on your individual needs and may be adjusted. Always adhere strictly to your prescribed regimen; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic benefits may not be apparent immediately; continue treatment as directed, even if you don't feel immediate improvement. Common side effects include elevated blood pressure, arthralgia, and anorexia. Diarrhea and dyspnea can be serious; address these promptly with prescribed medication or hydration. Regular blood pressure monitoring is typically recommended. Report severe headache, cognitive impairment, visual disturbances, nausea, or vomiting to your doctor. Prior to commencing treatment, inform your physician of any thyroid disorders, hepatic impairment, bleeding disorders, or concurrent use of antimicrobial agents. Interactions with other medications are possible; disclose all medications to your healthcare provider. This medication is contraindicated during pregnancy and lactation; reliable contraception is crucial for female patients undergoing treatment.
Uses of Axpero 5 Tablet
Renal cell carcinoma
Major Benefits of Axpero 5 Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Axpero 5 Tablet whole; avoid chewing, crushing, or breaking it. This medication can be taken with or without food, however, consistent timing is recommended.
Common Side effects of Axpero 5 Tablet:
- High blood pressure
- Joint pain
- Loss of appetite
- Diarrhea
- Breathing problems
- Abdominal pain
- Constipation
- Cough
- Decreased appetite
- Decreased level of thyroid hormones
- Difficulty in speaking
- Dry skin
- Indigestion
- Headache
- Nausea
- Pain in extremities
- Painful blisters on hands and feet
- Protein in urine
- Rash
- Breathlessness
- Stomatitis (Inflammation of the mouth)
- Taste change
- Vomiting
How to use Axpero 5 Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. The tablet should be swallowed whole; avoid chewing, crushing, or breaking it. Axpero 5 Tablets can be ingested with or without food, though consistent timing is recommended.
How Axpero 5 Tablet works:
Axpero 5 tablets are an anti-neoplastic agent. Their mechanism involves inhibiting the activity of a faulty protein responsible for triggering cancerous cell proliferation, thus hindering or decelerating tumor growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption with Axpero 5 Tablet may be unsafe; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Use of Axpero 5 Tablet is contraindicated during pregnancy due to established risks to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Using Axpero 5 Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Axpero 5 Tablet may cause drowsiness, blurred vision, or dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Axpero 5 Tablet presents no need for dosage modification in individuals with renal impairment and is considered safe for their use.
LiverCAUTION
Patients with liver impairment should use Axpero 5 Tablet cautiously, potentially requiring dose modification. Medical advice is recommended. Data regarding Axpero 5 Tablet's use in individuals with advanced liver disease is scarce.
What if you forget to take Axpero 5 Tablet :
NA
Facts to Know About Axpero 5 Tablet
Label | Value |
---|---|
Chemical Type | Indazole and Enzamide Derivatives |
Developing Habits | No. |
Treatment Category | Cancer Medications |
Behavior Class | Kinase inhibitors targeting tyrosine |